Authors

Antonio Muina, Miami Cancer InstituteFollow

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

Publication Date

3-10-2023

Content Type

Article

PubMed ID:

36603175

Additional Authors:

Additional authors and institutional affiliations

Citation

Coleman, J. A., Yip, W., Wong, N. C., Sjoberg, D. D., Bochner, B. H., Dalbagni, G., Donat, S. M., Herr, H. W., Cha, E. K., Donahue, T. F., Pietzak, E. J., Hakimi, A. A., Kim, K., Al-Ahmadie, H. A., Vargas, H. A., Alvim, R. G., Ghafoor, S., Benfante, N. E., Meraney, A. M., Shichman, S. J., … Bajorin, D. F. (2023). Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(8), 1618–1625. https://doi.org/10.1200/JCO.22.00763